perspective therapeutics | Home - Perspective Therapeutics

Keyword	CPC	PCC	Volume	Score	Length of keyword
perspective therapeutics	0.81	0.6	7028	35	24
perspective	0.58	0.8	3446	2	11
therapeutics	1.89	0.9	7537	20	12

Keyword	CPC	PCC	Volume	Score
perspective therapeutics	0.92	0.9	4319	21
perspective therapeutics stock	0.79	0.3	8359	24
perspective therapeutics news	0.31	0.5	3798	2
perspective therapeutics press release	1.3	0.4	3404	67
perspective therapeutics careers	0.84	0.6	9604	80
perspective therapeutics coralville	1.02	0.6	3667	50
perspective therapeutics stock price	1	0.7	6720	18
perspective therapeutics pipeline	1.36	0.7	6254	97
perspective therapeutics headquarters	1.57	0.7	3792	34
perspective therapeutics email	1.54	0.5	5956	47
perspective therapeutics ticker	0.65	0.3	5356	32
family matters a therapeutic perspective	1.92	0.1	1771	62
perspective therapeutics inc. stock	1.03	0.2	5781	28
catx perspective therapeutics	1.3	0.6	320	97
therapeutic perspective and modalities	0.88	0.9	9032	69

Search Results related to perspective therapeutics on Search Engine

Home - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/

WebFeb 26, 2024 · Our focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies so our targeted medical doses are delivered directly to the tumor site. We believe radiation should spare healthy tissues and be delivered from the inside out.

DA: 77 PA: 40 MOZ Rank: 9

About - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/about/

WebPerspective Therapeutics, Inc., is a clinical stage, radiopharmaceutical development company that is pioneering advanced treatments for cancers. The Company’s proprietary technology utilizes the alpha emitting isotope, Pb-212, to deliver powerful radiation specifically to cancer cells via targeting peptides.

DA: 42 PA: 9 MOZ Rank: 28

Latest News - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/newsroom

WebLatest News - Perspective Therapeutics. See the Latest news from Perspective Therapeutics. February 14, 2024. Perspective Therapeutics Oppenheimer 34th Annual Healthcare Life Sciences Conference Virtual. Targeted Imaging of Melanoma with Geoffrey Johnson, MD, PhD. Watch on. July 10, 2023.

DA: 99 PA: 40 MOZ Rank: 17

Press Releases - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/newsroom/press-releases

WebApr 8, 2024 · We are here to help you so you can make an informed treatment decision with your doctor. Search Use the search to find a Doctor that specializes in Brachytherapy using Cesium-131. See the latest Press Releases for Perspective Therapeutics.

DA: 80 PA: 90 MOZ Rank: 84

Theranostics - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/theranostics/

WebWe are developing a new, proprietary class of personalized alpha-particle radiopharmaceuticals to transform the treatment landscape of radiotherapies for cancer. Our unique theranostic approach provides the ability to diagnose the tumor and then treat it. Harnessing the Power of Alpha-Particles.

DA: 35 PA: 62 MOZ Rank: 24

Pipeline - Perspective Therapeutics
perspectivetherapeutics.com

https://perspectivetherapeutics.com/theranostics/pipeline

WebPipeline - Perspective Therapeutics. Theranostics. Targeted Alpha-Particle Radiotherapy for Cancer. VMT-𝛼-GEN: Elegantly Designed Pb-212 Isotope Generator. Publications. Pipeline. Theranostic Pipeline Leveraging the Power of Targeted Alpha-Particles.

DA: 84 PA: 23 MOZ Rank: 59

Perspective Therapeutics Initiates Phase 1/2a Clinical
globenewswire.com

https://www.globenewswire.com/news-release/2023/06/21/2691937/0/en/Perspective-Therapeutics-Initiates-Phase-1-2a-Clinical-Trials-for-Two-Targeted-Alpha-Therapy-Oncology-Product-Candidates.html

WebJun 21, 2023 · RICHLAND, WASHINGTON & CORALVILLE, IOWA , June 21, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a precision oncology company...

DA: 70 PA: 67 MOZ Rank: 30

Perspective Therapeutics Announces Clinical Collaboration
globenewswire.com

https://www.globenewswire.com/news-release/2024/03/18/2847755/0/en/Perspective-Therapeutics-Announces-Clinical-Collaboration-Agreement-with-Bristol-Myers-Squibb-to-Evaluate-212-Pb-VMT01-in-Combination-with-Nivolumab-in-MC1R-Positive-Metastatic-Mel.html

WebSEATTLE , March 18, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers...

DA: 6 PA: 82 MOZ Rank: 40

Perspective Therapeutics, Inc. (CATX) - Yahoo Finance
yahoo.com

https://finance.yahoo.com/quote/CATX

WebPerspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising...

DA: 35 PA: 48 MOZ Rank: 81

Perspective Therapeutics Announces First Patient Dosed in a
globenewswire.com

https://www.globenewswire.com/news-release/2023/12/07/2792460/0/en/Perspective-Therapeutics-Announces-First-Patient-Dosed-in-a-Phase-1-Study-of-212-Pb-VMT-%CE%B1-NET-to-Treat-Refractory-or-Relapsed-Neuroendocrine-Tumors.html

WebSEATTLE, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), announced today that the first patient was dosed at the...

DA: 67 PA: 19 MOZ Rank: 68